Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Analgesic agents revealed in recent patents

Nov. 3, 2005

Antibody-derived GLYX-13 possesses cognitive-enhancing properties

Nov. 3, 2005

Protocol accepted for phase IIb MS trial of Tovaxin

Nov. 3, 2005

Enrollment discontinued in phase III study of Reopro for acute ischemic stroke

Nov. 3, 2005

Escitalopram reported to improve kleptomania, PMDD and depression

Nov. 2, 2005

Positive phase I findings for Fentanyl Taifun

Nov. 2, 2005

Aripiprazole reported effective in preventing relapse of patients with bipolar disorder

Nov. 2, 2005

Vestipitant shows anxiolytic-like profile in rodent and primate behavioral models

Nov. 2, 2005

Aricept sNDA not accepted for filing due to formatting deficiencies

Oct. 31, 2005

Update on memantine in Alzheimer's disease and alcohol withdrawal

Oct. 31, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026